BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 7, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» CVN-417, a nicotinic α6 receptor antagonist for Parkinson’s disease motor dysfunction disclosed
To read the full story,
subscribe
or
sign in
.
Neurology/Psychiatric
CVN-417, a nicotinic α6 receptor antagonist for Parkinson’s disease motor dysfunction disclosed
April 6, 2023
Parkinson’s disease (PD) is a neurodegenerative...
BioWorld Science
Conferences
New compound
Neurology/psychiatric